Reata Pharmaceuticals Stock Buy Or Sell

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. What is the reata pharmaceuticals inc stock quote today?

Reata Pharmaceuticals Inc Reta Stock Price News Info The Motley Fool

According to the issued ratings of 3 analysts in the last year, the consensus rating for reata pharmaceuticals stock is buy based on the current 3 buy ratings for reta.

Reata pharmaceuticals stock buy or sell. When looking into those indicators for reata pharmaceuticals inc. (reta) reports q3 loss, tops revenue. Quote stock analysis news price vs fair value sustainability trailing returns.

This highflying biotech stock tumbled after shuttering two key studies; Reata pharmaceuticals has a 1 year low of $76.34 and a 1 year high of $184.00. Reata pharmaceuticals (nasdaq:reta) in the past three months, reata pharmaceuticals insiders have not sold or bought any company stock.

We're not expecting reata pharmaceuticals to pay a dividend over the next 12 months. The average price target is $217.25, with a high forecast of $244.00 and a low forecast of $155.00. Reata pharmaceuticals is not the only stock that insiders are buying.

Notably, that recent sale by colin meyer is the biggest insider sale of reata pharmaceuticals shares that we've seen in the last year. At reata pharmaceuticals, our mission is to develop innovative therapies that change patients’ lives for the better. Reta ) stock is to strong buy reta stock.

Is it the right time to buy or sell? Over the last 12 months, reata pharmaceuticals's shares have ranged in value from as little as $76.34 up to $186.817. Finally, we have a pdufa.

The reata pharmaceuticals inc stock price is 81.40 usd today. Is reata pharmaceuticals inc stock public? Shares of reata pharmaceuticals stock opened at $105.41 on thursday.

So we know that an insider sold shares at around the present. Yes, reata pharmaceuticals inc is a publicly traded company. This price target is based on 3 analysts offering 12 month price targets for reata pharmaceuticals in the last 3 months.

The consensus among 3 wall street analysts covering ( nasdaq : Reata pharmaceuticals inc is a. Reata pharmaceuticals share price volatility.

Is reata pharmaceuticals stock a good buy in 2021, according to wall street analysts? 23, 2017 at 8:50 a.m. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be.

A popular way to gauge a stock's volatility is its beta. (nasdaq:reta) is not the least popular stock in this group but hedge fund interest is still below average. 64.30% of the stock of reata pharmaceuticals is held by institutions.

Only 31.70% of the stock of reata pharmaceuticals is held by insiders. Out of 3 analysts, 3 ( 100% ) are recommending reta as a strong buy, 0 ( 0% ) are recommending reta as a buy, 0 ( 0% ) are recommending reta as a hold, 0 ( 0% ) are. Or recommendation to buy or sell securities.

Reata pharma shows rising relative strength; Make sure to utilize our earnings esp filter to uncover the best stocks to buy or sell before they've reported. Reata pharmaceuticals started at buy with $38 stock price target at stifel nicolaus.

However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Reata Pharmaceuticals Can Rally Nasdaqreta Seeking Alpha